ATOS
Price
$0.91
Change
+$0.05 (+5.81%)
Updated
Jun 26, 02:30 PM (EDT)
Capitalization
111.32M
53 days until earnings call
IGC
Price
$0.31
Change
-$0.00 (-0.00%)
Updated
Jun 26, 01:23 PM (EDT)
Capitalization
24.5M
43 days until earnings call
Interact to see
Advertisement

ATOS vs IGC

Header iconATOS vs IGC Comparison
Open Charts ATOS vs IGCBanner chart's image
Atossa Therapeutics
Price$0.91
Change+$0.05 (+5.81%)
Volume$300
Capitalization111.32M
IGC Pharma
Price$0.31
Change-$0.00 (-0.00%)
Volume$320
Capitalization24.5M
ATOS vs IGC Comparison Chart in %
Loading...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATOS vs. IGC commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATOS is a Buy and IGC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ATOS: $0.86 vs. IGC: $0.31)
Brand notoriety: ATOS and IGC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATOS: 142% vs. IGC: 84%
Market capitalization -- ATOS: $111.32M vs. IGC: $24.5M
ATOS [@Biotechnology] is valued at $111.32M. IGC’s [@Biotechnology] market capitalization is $24.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATOS’s FA Score shows that 1 FA rating(s) are green whileIGC’s FA Score has 0 green FA rating(s).

  • ATOS’s FA Score: 1 green, 4 red.
  • IGC’s FA Score: 0 green, 5 red.
According to our system of comparison, ATOS is a better buy in the long-term than IGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATOS’s TA Score shows that 4 TA indicator(s) are bullish while IGC’s TA Score has 4 bullish TA indicator(s).

  • ATOS’s TA Score: 4 bullish, 3 bearish.
  • IGC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ATOS is a better buy in the short-term than IGC.

Price Growth

ATOS (@Biotechnology) experienced а +7.30% price change this week, while IGC (@Biotechnology) price change was +2.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.69%. For the same industry, the average monthly price growth was +32.39%, and the average quarterly price growth was +15.29%.

Reported Earning Dates

ATOS is expected to report earnings on Aug 18, 2025.

IGC is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+1.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATOS($111M) has a higher market cap than IGC($24.5M). IGC (-8.482) and ATOS (-8.717) have similar YTD gains . IGC has higher annual earnings (EBITDA): -7.58M vs. ATOS (-28.04M). ATOS has more cash in the bank: 65.1M vs. IGC (470K). ATOS has less debt than IGC: ATOS (0) vs IGC (270K). IGC has higher revenues than ATOS: IGC (1.24M) vs ATOS (0).
ATOSIGCATOS / IGC
Capitalization111M24.5M453%
EBITDA-28.04M-7.58M370%
Gain YTD-8.717-8.482103%
P/E RatioN/AN/A-
Revenue01.24M-
Total Cash65.1M470K13,851%
Total Debt0270K-
FUNDAMENTALS RATINGS
ATOS vs IGC: Fundamental Ratings
ATOS
IGC
OUTLOOK RATING
1..100
633
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
5981
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATOS's Valuation (27) in the Medical Specialties industry is in the same range as IGC (47) in the Biotechnology industry. This means that ATOS’s stock grew similarly to IGC’s over the last 12 months.

ATOS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as IGC (100) in the Biotechnology industry. This means that ATOS’s stock grew similarly to IGC’s over the last 12 months.

ATOS's SMR Rating (97) in the Medical Specialties industry is in the same range as IGC (98) in the Biotechnology industry. This means that ATOS’s stock grew similarly to IGC’s over the last 12 months.

ATOS's Price Growth Rating (59) in the Medical Specialties industry is in the same range as IGC (81) in the Biotechnology industry. This means that ATOS’s stock grew similarly to IGC’s over the last 12 months.

ATOS's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as IGC (100) in the Biotechnology industry. This means that ATOS’s stock grew similarly to IGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATOSIGC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 11 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMICX22.40N/A
N/A
GMO International Equity II
SAGYX143.18N/A
N/A
ClearBridge Growth I
MSVYX17.71N/A
N/A
MassMutual Small Cap Opps Svc
MFWIX17.33N/A
N/A
MFS Global Total Return I
LSAGX22.82N/A
N/A
Loomis Sayles Global Growth A

IGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGC has been loosely correlated with TECX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IGC jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
-0.29%
TECX - IGC
49%
Loosely correlated
+0.89%
HOWL - IGC
31%
Poorly correlated
-4.40%
ANVS - IGC
30%
Poorly correlated
-25.16%
LRMR - IGC
30%
Poorly correlated
+8.70%
ATOS - IGC
27%
Poorly correlated
+4.33%
More